C

Colorado ENT & Allergy | Colorado Springs, CO

Research site

(Unclaimed)

Location

3030 N Circle Drive, Suite 300, Colorado Springs, Colorado, United States of America

Site insights

Top conditions

Top treatments

OPN-375

Omalizumab

OTO-313

OTO-104

Dexamethasone

ASP0598

Fluticasone Propionate

Lebrikizumab

BHV-3000

Ciprofloxacin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 18 total trials

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in participants with chronic rhinosinusitis and nasal polyps tr...

Enrolling

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Drug: Standard therapy for INCS

Drug: LY3650150

A Study of RhinAer Stylus for Treating Chronic Rhinitis (BIOKLEAR)

Post-market study to continue to evaluate the effectiveness of the RhinAer Stylus for chronic rhinitis and the effect of treatment on inflammatory bi...

Active, not recruiting

Chronic Rhinitis

Device: RhinAer Stylus

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of...

Enrolling

Asthma

Other: Placebo

Drug: PF-07275315

Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps (Re-Open 3)

This is a 12-Week randomized, double-blind, placebo-controlled, parallel-group, multicenter study evaluating the efficacy and safety of intranasal ad...

Enrolling

Chronic Rhinosinusitis Without Nasal Polyps

Drug: OPN-375

Drug: Placebo

Safety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA. (ACCCESS)

The solution offered by the Genio System to treat OSA patients with CCC using bilateral HGNS has a favorable risk-benefit ratio, as demonstrated by e...

Active, not recruiting

Sleep Apnea, Obstructive

Device: Genio System